Researchers Database

MASAWA MEITETSU

Affiliation： Department of Pulmonary Medicine and Clinical Immunology

Last Updated :2026/04/21

Original paper

間質性肺炎患者における筋炎関連自己抗体の陽性率と治療反応性及び予後についての検討., 森田弘子, 伊藤紘, 清水悠佳, 正和明哲, 中村祐介, 小池亮介, 奥冨泰明, 渡邊泰治, 横山達也, 曾田紗世, 塩原太一, 池田直哉, 新井良, 知花和行, 武政聡浩, 倉沢和宏, 清水泰生, DJMS, 47, 105, 2020

Unclear

Endocrine secretory granule production is caused by a lack of REST and intragranular secretory content and accelerated by PROX1., Ishii Jun;Sato-Yazawa Hanako;Kashiwagi Korehito;Nakadate Kazuhiko;Iwamoto Masami;Kohno Kakeru;Miyata-Hiramatsu Chie;Masawa Meitetsu;Onozaki Masato;Noda Shuhei;Miyazawa Tadasuke;Takagi Megumi;Yazawa Takuya, Journal of molecular histology, 53(2), 437-448, 30 Jan. 2022
DOI

Carboplatin plus nab-paclitaxel for recurrent small cell lung cancer: A phase II study., Ikeda Naoya;Arai Ryo;Soda Sayo;Inoue Takashi;Uchida Nobuhiko;Nakamura Yusuke;Masawa Meitetsu;Kushima Yoshitomo;Okutomi Hiroaki;Takemasa Akihiro;Shimizu Yasuo;Niho Seiji, Thoracic cancer, 13(9), 1342-1348, 22 Mar. 2022
DOI

REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine Carcinoma., Masawa Meitetsu;Sato-Yazawa Hanako;Kashiwagi Korehito;Ishii Jun;Miyata-Hiramatsu Chie;Iwamoto Masami;Kohno Kakeru;Miyazawa Tadasuke;Onozaki Masato;Noda Shuhei;Shimizu Yasuo;Niho Seiji;Yazawa Takuya, The American journal of pathology, 192(6), 847-861, 30 Mar. 2022
DOI

REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine Carcinoma., Masawa Meitetsu;Sato-Yazawa Hanako;Kashiwagi Korehito;Ishii Jun;Miyata-Hiramatsu Chie;Iwamoto Masami;Kohno Kakeru;Miyazawa Tadasuke;Onozaki Masato;Noda Shuhei;Shimizu Yasuo;Niho Seiji;Yazawa Takuya, The American journal of pathology, 192(6), 847-861, 30 Mar. 2022
DOI

Changes in Peripheral Blood Eosinophil Counts and Risk of Eosinophilic Granulomatosis with Polyangiitis Onset after Initiation of Dupilumab Administration in Adult Patients with Asthma., Kushima Yoshitomo;Shimizu Yasuo;Hoshi Hiromi;Arai Ryo;Ikeda Naoya;Nakamura Yusuke;Masawa Meitetsu;Okutomi Hiroaki;Yazawa Nana;Chibana Kazuyuki;Takemasa Akihiro;Niho Seiji, Journal of clinical medicine, 12(17), 01 Sep. 2023
DOI

Dysregulated metabolic pathways of pulmonary fibrosis and the lipids associated with the effects of nintedanib therapy., Shimizu Yasuo;Horibata Yasuhiro;Domae Mariko;Nakamura Yusuke;Yokoyama Tatsuya;Arai Ryo;Shiobara Taichi;Takemasa Akihiro;Koike Ryosuke;Uchida Nobuhiko;Masawa Meitetsu;Tei Rinna;Watanabe Taiji;Morita Hiroko;Miyoshi Masaaki;Soda Sayo;Niho Seiji;Igami Ko;Sugimoto Hiroyuki, Respiratory research, 26(1), 166, 28 Apr. 2025
DOI

Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control study., Kushima Yoshitomo;Shimizu Yasuo;Arai Ryo;Chibana Kazuyuki;Shimizu Yuka;Amagai Masahiro;Takemasa Akihiro;Ikeda Naoya;Masawa Meitetsu;Kushima Atsushi;Okutomi Hiroaki;Nakamura Yusuke;Tei Rinna;Ando Yuki;Yazawa Nana;Goto Yuto;Haruyama Yasuo;Yukawa Tatsuo;Niho Seiji, Frontiers in allergy, 6, 1537501, 17 Mar. 2025
DOI

Corrigendum to "Transcutaneous gas monitoring is a useful tool to detect respiratory depression during bronchoscopy performed under propofol sedation" [Resp. Invest. 61 (2023) 793-799]., Yazawa Nana;Nakamura Yusuke;Takemasa Akihiro;Uchida Nobuhiko;Kushima Yoshitomo;Masawa Meitetsu;Okutomi Hiroaki;Soda Sayo;Ikeda Naoya;Arai Ryo;Chibana Kazuyuki;Niho Seiji;Shimizu Yasuo, Respiratory investigation, 62(2), 295, 30 Jan. 2024
DOI

Transcutaneous gas monitoring is a useful tool to detect respiratory depression during bronchoscopy performed under propofol sedation., Yazawa Nana;Nakamura Yusuke;Takemasa Akihiro;Uchida Nobuhiko;Kushima Yoshitomo;Masawa Meitetsu;Okutomi Hiroaki;Soda Sayo;Ikeda Naoya;Arai Ryo;Chibana Kazuyuki;Niho Seiji;Shimizu Yasuo, Respiratory investigation, 61(6), 793-799, 27 Sep. 2023
DOI